Lincoln Pharmaceuticals Limited
Lincoln Pharmaceuticals Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: LINCOLN and BSE: 531633 (ISIN INE405C01035).
It has a market capitalisation of ₹1,072 crore, a last close of ₹535.35 on 2026-10-19, a one-year return of 2.1%.
Valuation: a price-to-book ratio of 1.42x, a dividend yield of 0.3%.
Profitability: return on equity of 0.0%, return on capital employed of 15.9%, an operating margin of 14.6%.
Growth: sales growth of 9.6% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.01x, promoter holding of 49.8%.
| Metric | Value |
|---|---|
| Market capitalisation | 1,072 |
| Last close | ₹535.35 |
| P/B | 1.42x |
| Dividend yield | 0.3% |
| ROE (FY) | 0.0% |
| ROCE (FY) | 15.9% |
| Operating margin (TTM) | 14.6% |
| Sales growth, 3-year CAGR | 9.6% |
| Debt / equity | 0.01x |
| Promoter holding | 49.8% |
| 1-year return | 2.1% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means